SOURCE: Equity Markets Inc

October 04, 2011 09:00 ET

US Domestic, Global Economic Outlook - Equity Research on PharMerica Corporation and Omnicare, Inc.

MACAU--(Marketwire - Oct 4, 2011) - Today, www.EquityMarketsInc.com announced its research report highlighting PharMerica Corporation (NYSE: PMC) and Omnicare, Inc. (NYSE: OCR). Full content and research is available at www.EquityMarketsInc.com/research.php?id=PMC+OCR.

Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets.'

As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.

Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.

Equity Markets has reviewed PharMerica Corporation for its current position within the services industry. PharMerica Corporation is an institutional pharmacy services company, which services healthcare facilities and provides management pharmacy services to hospitals. The Company operates in two segments: institutional pharmacies and hospital pharmacy management. The full research report on PharMerica Corporation (NYSE: PMC) is available here: www.EquityMarketsInc.com/research.php?id=PMC.

Equity Markets has reviewed Omnicare, Inc. for its development within the services industry. Omnicare, Inc. (Omnicare) is a pharmaceutical services company. Omnicare operates two business segments: Pharmacy Services and contract research organization services (CRO Services). It is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term healthcare institutions. The full research report on Omnicare, Inc. (NYSE: OCR) is available here: www.EquityMarketsInc.com/research.php?id=OCR.

About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.

Contact Information